Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine in Acute Ischemic Stroke
NCT06656442Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Sep 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimetazidine in ischemic stroke, sponsored by Ain Shams University. Started Sep 2024; status: completed.
02
Drugs
trimetazidine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06656442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06656442.